Home · Open Lab · Lot RGX-26-RGNX-738
RGX-26-RGNX-738Superseded
Thymosin Alpha-1 · 5 MG · Immune Research · COA NS-2026-05199

Release test results

99.672%HPLC purity · meets ≥ 99.5% spec
Mass-spec identityConfirmed · 5.01 mg
Related impurities (total)0.328%
Endotoxin<1.0 EU/mg
HPLC retention time7.1 min
MethodHPLC + LC-MS
ResultPass · meets spec
Verify COA at Nordicstar Labs → All certificates

Lot record

CompoundThymosin Alpha-1
Presentation5 MG
Lot numberRGX-26-RGNX-738
COA numberNS-2026-05199
Test date05 Sep 2026
Release date08 Sep 2026
Independent labNordicstar Labs
StatusSuperseded

Thymosin Alpha-1 — lot history

LotPresentationTestedHPLC purityStatus
RGX-26-RGNX-10625 MGSep 7, 202699.592%Current
RGX-26-RGNX-106310 MGSep 7, 202699.768%Current
RGX-26-RGNX-63710 MGSep 7, 202699.737%Superseded
RGX-26-RGNX-738 this lot5 MGSep 5, 202699.672%Superseded
RGX-26-RGNX-73710 MGSep 5, 202699.699%Superseded
RGX-26-RGNX-6385 MGSep 3, 202699.661%Superseded
!
Research use only

This lot record documents a research compound sold for laboratory use only — not for human or animal consumption. Results are as tested by Nordicstar Labs; retained samples are archived for five years. Research Use Agreement →